CENTESSA PHARMACEUTICALS PLC: total liabilities
Total liabilities for CENTESSA PHARMACEUTICALS PLC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All CENTESSA PHARMACEUTICALS PLC financial histories
What this measure means
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
Exact concept: us-gaap:Liabilities. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2020-12-31 to 2025-12-31. The SEC response was captured on 2026-09-21.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2025-12-31 | 160,632,000 | USD | 2026-03-31 | 10-K · 0001847903-26-000025 |
| At date | 2024-12-31 | 175,253,000 | USD | 2026-03-31 | 10-K · 0001847903-26-000025 |
| At date | 2023-12-31 | 124,002,000 | USD | 2025-03-24 | 10-K · 0001847903-25-000051 |
| At date | 2022-12-31 | 108,138,000 | USD | 2024-03-28 | 10-K · 0001847903-24-000054 |
| At date | 2021-12-31 | 138,081,000 | USD | 2023-03-30 | 10-K · 0001847903-23-000063 |
| At date | 2020-12-31 | 8,619,000 | USD | 2022-03-30 | 10-K · 0001847903-22-000022 |
Related financial histories
- CENTESSA PHARMACEUTICALS PLC: total assets
- CENTESSA PHARMACEUTICALS PLC: stockholders equity
- CENTESSA PHARMACEUTICALS PLC: cash and cash equivalents
- CENTESSA PHARMACEUTICALS PLC: net income or loss
- CENTESSA PHARMACEUTICALS PLC: operating cash flow
- CENTESSA PHARMACEUTICALS PLC: capital expenditure payments
- CENTESSA PHARMACEUTICALS PLC: revenue
- CENTESSA PHARMACEUTICALS PLC: financing cash flow
- CENTESSA PHARMACEUTICALS PLC: investing cash flow
- CENTESSA PHARMACEUTICALS PLC: retained earnings or deficit
- CENTESSA PHARMACEUTICALS PLC: basic weighted-average shares
- CENTESSA PHARMACEUTICALS PLC: diluted weighted-average shares
- CENTESSA PHARMACEUTICALS PLC: basic earnings per share
- CENTESSA PHARMACEUTICALS PLC: diluted earnings per share
- CENTESSA PHARMACEUTICALS PLC: income tax expense or benefit
- CENTESSA PHARMACEUTICALS PLC: net property, plant and equipment
- CENTESSA PHARMACEUTICALS PLC: share-based compensation expense
- CENTESSA PHARMACEUTICALS PLC: operating income or loss
- CENTESSA PHARMACEUTICALS PLC: current assets
- CENTESSA PHARMACEUTICALS PLC: current liabilities
- CENTESSA PHARMACEUTICALS PLC: current accounts payable
- CENTESSA PHARMACEUTICALS PLC: common-stock repurchase payments
Inspect the source
- Entity
- CENTESSA PHARMACEUTICALS PLC / CIK 0001847903
- Captured
- 2026-09-21T17:30:30.002Z
- SEC response SHA-256
44cb5029fad93a8a1de4e07b2d3209095726ec0142ae420012bc4af342a8f265
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001847903.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))